Enfermedades Sistémicas de Base Autoinmune

Alvaro, JMAG; Fontecha, PDD; Sánchez, JLA; Criado, AB; Cáliz, RC; Fernández, IC; Corominas, H; Puerta, JAG; Arija, SM; Vázquez, NM; García, AO; Rodríguez, CP; Fernández, LS; Molina, JT.

Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis

Reumatologia Clinica. 2024; 20(8): 423-439 Nº de citas: 2 [doi:10.1016/j.reuma.2024.05.007]

Martínez-Vidal, MP; Fernández-Carballido, C; Otero-Varela, L; Ruiz, FJM; Pérez-Vera, Y; Arijao, SM; Fernández, CC; Jovaní, V; Expósito, L; Lario, BA; García-González, J; Sánchez-Alonso, F; Castrejón, I.

Long-Term Survival of Subcutaneous Biosimilar Tumor Necrosis Factor Inhibitors Compared to Originators: Results From a Multicenter Prospective Registry

JOURNAL OF RHEUMATOLOGY. 2024; 51(9): 877-883 [doi:10.3899/jrheum.2024-0001]

Garcia-Villanueva, MJ; Garrote-Corral, S; Pego-Reigosa, JM; Otero, NJ; Isazelaia, EU; Marqué, AO; Gómez, CS; González, MF; Aguinaga, EA; Alvarez, ER; Muriel, ET; Morales, CM; Izquierdo, MG; Calvo-Alén, J; Menor-Almagro, R; Benavente, BS; Martinez-Barrio, J; Hernández-Beriain, JA; Barceló, MI; Hernan, GB; Rosas, J; Pérez, ES; Fernández-Nebro, A; Rua-Figueroa, I.

Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

RHEUMATOLOGY INTERNATIONAL. 2024; : Nº de citas: 1 [doi:10.1007/s00296-024-05684-4]

Linde, L; Georgiadis, S; Ornbjerg, LM; Rasmussen, SH; Michelsen, B; Askling, J; Di Giuseppe, D; Wallman, JK; Závada, J; Pavelka, K; Bernardes, M; Matos, CO; Glintborg, B; Loft, AG; Nordström, D; Kuusalo, L; Möller, B; Nissen, MJ; Codreanu, C; Mogosan, C; Gudbjornsson, B; Love, TJ; Akleylek, C; Iannone, F; Kvien, TK; Rotar, Z; Castrejon, I; Macfarlane, GJ; Hetland, ML; Ostergaard, M.

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

ARTHRITIS CARE & RESEARCH. 2024; 76(11): 1558-1565 Nº de citas: 1 [doi:10.1002/acr.25396]

Altabás-González, I; Rua-Figueroa, I; Mouriño, C; Roberts, K; Jimenez, N; Martinez-Barrio, J; Galindo, M; Alen, JC; Perez, VD; Itzazelaia, EU; Tomero, E; Freire-Gonzalez, M; Taboada, VM; Salgado, E; Vela, P; Fernandez-Nebro, A; Olive, A; Narvaez, J; Menor-Almagro, R; Soler, GS; Hernandez-Beriain, JA; Manero, J; Aurrecoechea, E; Ibarguengoitia-Barrena, O; Montilla, C; Bonilla, G; Torrente-Segarra, V; Cacheda, AP; Garcia-Villanueva, MJ; Moriano-Morales, C; Manteca, CF; Lozano-Rivas, N; Bohorquez, C; Pego-Reigosa, JM.

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

LUPUS SCIENCE & MEDICINE. 2024; 11(2): 1-10 Nº de citas: 1 [doi:10.1136/lupus-2023-001064]

Christiansen, SN; Rasmussen, SH; Ostergaard, M; Pons, M; Michelsen, B; Pavelka, K; Codreanu, C; Ciurea, A; Glintborg, B; Santos, MJ; Sari, I; Rotar, Z; Gudbjornsson, B; Macfarlane, GJ; Relas, H; Iannone, F; Laas, K; Wallman, JK; van de Sande, M; Provan, SA; Castrejon, I; Zavada, J; Mogosan, C; Nissen, MJ; Loft, AG; Barcelos, A; Erez, Y; Pirkmajer, KP; Grondal, G; Jones, GT; Hokkanen, AM; Chimenti, MS; Vorobjov, S; Di Giuseppe, D; Kvien, TK; Otero-Varela, L; van der Horst-bruinsma, I; Hetland, ML; Ornbjerg, LM.

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study

Rmd Open. 2024; 10(3): Nº de citas: 2 [doi:10.1136/rmdopen-2024-004166]

Hellamand, P; van de Sande, MGH; Nurmohamed, MT; van Vollenhoven, RF; Hollick, RJ; Rotariu, O; Rotar, Z; Pirkmajer, KP; Nordström, D; Hokkanen, AM; Michelsen, B; Kvien, TK; Glintborg, B; Hetland, ML; Ostergaard, M; Loft, AG; Pavelka, K; Zavada, J; Castrejon, I; Otero-Varela, L; Gudbjornsson, B; Palsson, O; Olofsson, T; Wallman, JK; Ciurea, A; Nissen, MJ; Yildirim, TD; Onen, F; Codreanu, C; Mogosan, C; Santos, MJ; Vieira-Sousa, E; Iannone, F; Frediani, B; Ornbjerg, LM; Twisk, JWR; van der Horst-bruinsma, IE.

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

RHEUMATOLOGY. 2024; 64(4): 1853-1863 Nº de citas: 2 [doi:10.1093/rheumatology/keae370]

Carriquí-Arenas, S; Mosquera, JM; Quesada-Masachs, E; López, M; Clemente, D; Boteanu, A; Udaondo, C; de Inocencio, J; Nieto, JC; Riancho, L; Núñez, E; Sánchez-Manubens, J; Lirola, MJ; Roldán, R; Camacho, M; Martínez, M; Medrano, M; Alcañiz, P; Antón, J; Iglesias, E.

Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry

Pediatric Rheumatology. 2024; 22(1): Nº de citas: 2 [doi:10.1186/s12969-024-00999-9]

Smith, CS; Reyes, FJM; Chicote, AC; Barrio, JM; Vieru, M; Herrera, IH; Arias, F; Ginés, MM; Domínguez, JMG.

Rheumatoid meningitis: a case series report and review of modern therapeutic schemes and outcome

NEUROLOGICAL SCIENCES. 2024; 45(12): 5875-5887 [doi:10.1007/s10072-024-07681-8]

Castrejón, I; Cano, L; Cuadrado, MJ; Borrás, J; Galindo, M; Salman-Monte, TC; Amorós, C; Román, CS; Cabezas, I; Comellas, M; Muñoz, A.

Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care

Bmc Rheumatology. 2024; 8(1): Nº de citas: 1 [doi:10.1186/s41927-024-00401-x]

Rua-Figueroa, I; Altabás-González, I; Mouriño, C; Roberts, K; Hernández-Martín, A; Casafont-Solé, I; Font-Urgelles, J; Roman-Ivorra, JA; Navarro, MD; Galindo-Izquierdo, M; Salman-Monte, TC; Narváez, J; Vidal-Montal, P; García-Villanueva, MJ; Garrote-Corral, S; Blazquez-Canamero, MA; Fernandez-Cid, CM; Piqueras-García, M; Martínez-Barrio, J; Sánchez-Lucas, M; Cortés-Hernández, J; Penzo, E; Calvo-Alén, J; de Dios, JR; Alvarez-Rodríguez, B; Vasques-Rocha, M; Tomero, E; Menor-Almagro, R; Gandía, M; Gómez-Puerta, JA; Frade-Sosa, B; Ramos-Giráldez, C; Trapero-Pérez, C; Diez, E; Moriano, C; Muñoz-Jiménez, A; Pego-Reigosa, JM.

Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

RHEUMATOLOGY. 2024; 64(3): 1220-1224 Nº de citas: 1 [doi:10.1093/rheumatology/keae270]

Mesa-del-Castillo, P; Ugarte, IY; Bolarín, JM; Martínez, D; Montesinos, BL; González, HB; Penadés, IC; Pérez, LL; Clemente, D; Robledillo, JC; Ferrán, IV; Mancheño, BB; Plats, MR; Pedraz, LM; Linero, CA; Sevilla-Pérez, B; García-Serrano, JL; Mir-Perelló, MC; Druetta, N; Souto, A; Lopez-Lopez, F; Zarallo-Reales, C; Fidalgo, MJ; Fajardo, JS; Fontana, NP; Pablo, RD; Pinedo, MC; Fonollosa, A; Casano, VJ; García, JJM; Brandy, A; López, AG; Esteban-Ortega, M; Reinoso, T; Calzada-Hernández, J; Cardeñosa, AL; Martín, CG; Verdú, EM; Vidal, MPM; Martí, NQ; Alvarado, MC; De Inocencio, J; Alonso-Martín, B; Recuero-Diaz, S; Carreño, E; González, JCN; Ibares, L; de Salazar, JRG; Sevila, JL.

Childhood-Onset Non-Infectious Uveitis in the "Biologic Era". Results From Spanish Multicenter Multidisciplinary Real-World Clinical Settings

OCULAR IMMUNOLOGY AND INFLAMMATION. 2024; 32(9): 2159-2169 Nº de citas: 1 [doi:10.1080/09273948.2024.2336609]

Molina-Collada, J; Monjo-Henry, I; Fernández-Fernández, E; Alvaro-Gracia, JM; De Miguel, E.

The OMERACT giant cell arteritis ultrasonography score: a potential predictive outcome for assessing the risk of relapse during follow-up

RHEUMATOLOGY. 2024; 64(3): 1448-1452 Nº de citas: 2 [doi:10.1093/rheumatology/keae260]

Garcia-Pompermayer, MR; Ayton, SG; Molina-Collada, J; Tamborrini, G; Sanchez, MED; Luna, KS; Elizondo, MAG.

The power of us: breaking barriers and bridging the gap of ultrasound in rheumatology to empower a new generation

CLINICAL RHEUMATOLOGY. 2024; 43(6): 2103-2116 Nº de citas: 1 [doi:10.1007/s10067-024-06973-w]

Herández-Cruz, B; Otero-Varela, L; Freire-González, M; Busquets-Pérez, N; González, AJG; Moreno-Ramos, M; Blanco-Madrigal, JM; Manrique-Arija, S; Perez-Pampin, E; Ruiz-Montesino, D; Sánchez-Alonso, F; Sanchez-Piedra, C; Castrejón, I.

Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

ANNALS OF THE RHEUMATIC DISEASES. 2024; 83(9): 1189-1199 [doi:10.1136/ard-2023-225271]

García-Dorta, A; González-Dávila, E; Sánchez-Jareño, M; Cea-Calvo, L; Pombo-Suárez, M; Sánchez-Alonso, F; Castrejón, I; Díaz-González, F.

Early identification of golimumab-treated patients with higher likelihood of long-term retention

Frontiers in Immunology. 2024; 15: Nº de citas: 1 [doi:10.3389/fimmu.2024.1359571]

Izquierdo, MG; Blasco, JB; Ortega, SP; Salman-Monte, TC; Vela-Casasempere, P; Almaraz, ER; Calvo-Alen, J; Alvaro, JMAG; Ajo, MJB; Renau, RR; Galvez-Fernandez, M; Bahamontes-Rosa, N; Hernández, JSC; Marsiñach, CS.

Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study

LUPUS. 2024; 33(7): 663-674 Nº de citas: 3 [doi:10.1177/09612033241242886]

Rua-Figueroa, I; de Yébenes, MJG; Martinez-Barrio, J; Izquierdo, MG; Alén, J; Fernandez-Nebro, A; Menor-Almagro, R; Carmona, L; Segura, BT; Tomero, E; Freire-González, M; Sangüesa, C; Horcada, L; Blanco, R; Itzazelaia, EU; Narvaez, J; de Salazar, JCRG; Gómez-Sabater, S; Morales, CM; Andreu, JL; Segarra, VT; Aurrecoechea, E; Perez, A; Medina, JN; Salgado, E; Lozano-Rivas, N; Montilla, C; Ruiz-Lucea, E; Arevalo, M; Iñiguez, C; García-Villanueva, MJ; Exposito, L; Ibáñez-Barcelo, M; Bonilla, G; Carrión-Barberà, I; Erausquin, C; Gil, JJF; Pecondón, A; Toyos, FJ; Cobo, T; Muñoz-Jiménez, A; Oller, J; Nolla, JM; Pego-Reigosa, JM.

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

LUPUS SCIENCE & MEDICINE. 2024; 11(1): Nº de citas: 2 [doi:10.1136/lupus-2023-001096]